Haldar S, Jena N, DuBois G C, Takayama S, Reed J C, Fu S S, Croce C M
Department of Microbiology and Immunology, Thomas Jefferson University, Philadelphia, Pennsylvania 19107.
Arch Biochem Biophys. 1994 Dec;315(2):483-8. doi: 10.1006/abbi.1994.1529.
The oncogene product bcl-2 functions as a repressor of programmed cell death and is a 26-kDa protein with a single predicted transmembrane segment located at the carboxyl terminus. The bcl-2 protein seems to function in different subcellular compartments, as evidenced by several biochemical and ultrastructural studies. The present study was performed to purify bcl-2 protein in significant quantities necessary for structural and functional studies. For this purpose, the bcl-2 gene was over-expressed in either baculovirus system or lymphocytes. Initially, attempts were undertaken to purify bcl-2 protein using conventional methods such as ion exchange or gel filtration chromatography. During these purification attempts we determined that bcl-2 protein is highly hydrophobic and prone to aggregation as might be expected for an integral membrane protein. By ion exchange and gel filtration chromatography, this protein could be partially purified. In order to purify bcl-2 to apparent homogeneity and avoid the aggregation problem, we prepared immunoaffinity columns using a monoclonal antibody developed against a synthetic peptide chosen from residues 61-76 of the amino acid sequence of human bcl-2. The antibody was either coupled to CNBr-activated Sepharose 4B or cross-linked into protein A-Sepharose by dimethylpimelimidate dihydrochloride. Cellular extract equivalent to 10(8) bcl-2-overexpressing insect cells or lymphocytes was applied to immunoaffinity columns. Approximately 500 micrograms purified bcl-2 protein could be recovered as estimated by silver staining and immunoblotting. Furthermore, purified bcl-2 protein was electroporated into Pre-B lymphocytes which do not express this protein in sufficient quantity to delay the onset of glucocorticoid-induced apoptosis.(ABSTRACT TRUNCATED AT 250 WORDS)
癌基因产物bcl-2作为程序性细胞死亡的抑制因子发挥作用,是一种26 kDa的蛋白质,其唯一预测的跨膜区段位于羧基末端。几项生化和超微结构研究表明,bcl-2蛋白似乎在不同的亚细胞区室中发挥作用。本研究旨在大量纯化bcl-2蛋白,以满足结构和功能研究的需要。为此,bcl-2基因在杆状病毒系统或淋巴细胞中过表达。最初,尝试使用离子交换或凝胶过滤色谱等传统方法纯化bcl-2蛋白。在这些纯化尝试过程中,我们确定bcl-2蛋白具有高度疏水性,并且易于聚集,这对于一种整合膜蛋白来说是可以预料的。通过离子交换和凝胶过滤色谱,该蛋白可以得到部分纯化。为了将bcl-2纯化至表观均一性并避免聚集问题,我们使用针对从人bcl-2氨基酸序列的61 - 76位残基中选择的合成肽制备的单克隆抗体制备了免疫亲和柱。该抗体要么偶联到溴化氰活化的琼脂糖凝胶4B上,要么通过二盐酸二甲基庚二酸亚胺交联到蛋白A - 琼脂糖凝胶中。将相当于10⁸个过表达bcl-2的昆虫细胞或淋巴细胞的细胞提取物应用于免疫亲和柱。通过银染和免疫印迹估计,可回收约500微克纯化的bcl-2蛋白。此外,将纯化的bcl-2蛋白电穿孔导入前B淋巴细胞,这些细胞中该蛋白的表达量不足以延迟糖皮质激素诱导的细胞凋亡的发生。(摘要截短于250词)